S100A8 and myocardial infarction: In the early phase of myocardial infarction, S100A8/A9 released from neutrophils leads to the activation of proinflammatory signaling pathways, such as NF-κB or MAPK, that recruit additional inflammatory cells and promote the release of inflammatory cytokines, amplifying the inflammatory response (Figure 4).